ID   GLDSA_BACCI             Reviewed;         418 AA.
AC   Q8G8Y2;
DT   18-APR-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   26-NOV-2014, entry version 50.
DE   RecName: Full=L-glutamine:2-deoxy-scyllo-inosose aminotransferase;
DE            Short=L-glutamine:DOI aminotransferase;
DE            EC=2.6.1.100;
DE   AltName: Full=L-glutamine:3-amino-2,3-dideoxy-scyllo-inosose aminotransferase;
DE            Short=L-glutamine:amino-DOI aminotransferase;
DE            EC=2.6.1.101;
GN   Name=btrR; Synonyms=btrS;
OS   Bacillus circulans.
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus.
OX   NCBI_TaxID=1397;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=12478783; DOI=10.1039/b209799k;
RA   Huang F., Li Y., Yu J., Spencer J.B.;
RT   "Biosynthesis of aminoglycoside antibiotics: cloning, expression and
RT   characterisation of an aminotransferase involved in the pathway to 2-
RT   deoxystreptamine.";
RL   Chem. Commun. (Camb.) 23:2860-2861(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND CATALYTIC ACTIVITY.
RC   STRAIN=SANK 72073;
RX   PubMed=12374384;
RA   Tamegai H., Nango E., Kuwahara M., Yamamoto H., Ota Y., Kuriki H.,
RA   Eguchi T., Kakinuma K.;
RT   "Identification of L-glutamine: 2-deoxy-scyllo-inosose
RT   aminotransferase required for the biosynthesis of butirosin in
RT   Bacillus circulans.";
RL   J. Antibiot. 55:707-714(2002).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, AND REACTION STEREOCHEMISTRY.
RC   STRAIN=SANK 72073;
RX   PubMed=15839685; DOI=10.1021/ja0445948;
RA   Yokoyama K., Kudo F., Kuwahara M., Inomata K., Tamegai H., Eguchi T.,
RA   Kakinuma K.;
RT   "Stereochemical recognition of doubly functional aminotransferase in
RT   2-deoxystreptamine biosynthesis.";
RL   J. Am. Chem. Soc. 127:5869-5874(2005).
CC   -!- FUNCTION: Catalyzes the PLP-dependent transamination of 2-deoxy-
CC       scyllo-inosose (DOI) to form 2-deoxy-scyllo-inosamine (DOIA) using
CC       L-glutamine as the amino donor. Also catalyzes the transamination
CC       of 3-amino-2,3-dideoxy-scyllo-inosose (amino-DOI) into 2-
CC       deoxystreptamine (DOS). Is also able to catalyze the
CC       transamination of scyllo-inosose to form scyllo-inosamine,
CC       although this reaction may be not physiological.
CC       {ECO:0000269|PubMed:12374384, ECO:0000269|PubMed:12478783,
CC       ECO:0000269|PubMed:15839685}.
CC   -!- CATALYTIC ACTIVITY: L-glutamine + 2-deoxy-scyllo-inosose = 2-
CC       oxoglutaramate + 2-deoxy-scyllo-inosamine.
CC   -!- CATALYTIC ACTIVITY: L-glutamine + 3-amino-2,3-dideoxy-scyllo-
CC       inosose = 2-oxoglutaramate + 2-deoxystreptamine.
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000250};
CC   -!- PATHWAY: Metabolic intermediate biosynthesis; 2-deoxystreptamine
CC       biosynthesis; 2-deoxystreptamine from D-glucose 6-phosphate: step
CC       2/4.
CC   -!- PATHWAY: Metabolic intermediate biosynthesis; 2-deoxystreptamine
CC       biosynthesis; 2-deoxystreptamine from D-glucose 6-phosphate: step
CC       4/4.
CC   -!- PATHWAY: Antibiotic biosynthesis; butirosin biosynthesis.
CC   -!- SIMILARITY: Belongs to the DegT/DnrJ/EryC1 family. L-glutamine:2-
CC       deoxy-scyllo-inosose/scyllo-inosose aminotransferase subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ494863; CAD41947.1; -; Genomic_DNA.
DR   EMBL; AB097196; BAE07061.1; -; Genomic_DNA.
DR   PDB; 2C7T; X-ray; 2.10 A; A=1-418.
DR   PDB; 2C81; X-ray; 1.70 A; A=1-418.
DR   PDBsum; 2C7T; -.
DR   PDBsum; 2C81; -.
DR   ProteinModelPortal; Q8G8Y2; -.
DR   SMR; Q8G8Y2; 6-416.
DR   BioCyc; MetaCyc:MONOMER-17229; -.
DR   UniPathway; UPA00907; UER00922.
DR   UniPathway; UPA00907; UER00924.
DR   UniPathway; UPA00964; -.
DR   EvolutionaryTrace; Q8G8Y2; -.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0008483; F:transaminase activity; IEA:UniProtKB-KW.
DR   GO; GO:0017000; P:antibiotic biosynthetic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.640.10; -; 1.
DR   Gene3D; 3.90.1150.10; -; 1.
DR   InterPro; IPR000653; DegT/StrS_aminotransferase.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major_sub1.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_major_sub2.
DR   Pfam; PF01041; DegT_DnrJ_EryC1; 1.
DR   PIRSF; PIRSF000390; PLP_StrS; 1.
DR   SUPFAM; SSF53383; SSF53383; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aminotransferase; Antibiotic biosynthesis;
KW   Pyridoxal phosphate; Transferase.
FT   CHAIN         1    418       L-glutamine:2-deoxy-scyllo-inosose
FT                                aminotransferase.
FT                                /FTId=PRO_0000233016.
FT   MOD_RES     192    192       N6-(pyridoxal phosphate)lysine.
FT                                {ECO:0000250}.
FT   HELIX        16     28       {ECO:0000244|PDB:2C81}.
FT   HELIX        43     55       {ECO:0000244|PDB:2C81}.
FT   STRAND       58     64       {ECO:0000244|PDB:2C81}.
FT   HELIX        66     76       {ECO:0000244|PDB:2C81}.
FT   STRAND       84     91       {ECO:0000244|PDB:2C81}.
FT   HELIX        94    101       {ECO:0000244|PDB:2C81}.
FT   STRAND      105    109       {ECO:0000244|PDB:2C81}.
FT   TURN        113    115       {ECO:0000244|PDB:2C81}.
FT   HELIX       120    123       {ECO:0000244|PDB:2C81}.
FT   HELIX       124    126       {ECO:0000244|PDB:2C81}.
FT   STRAND      131    134       {ECO:0000244|PDB:2C81}.
FT   HELIX       146    155       {ECO:0000244|PDB:2C81}.
FT   STRAND      159    163       {ECO:0000244|PDB:2C81}.
FT   STRAND      179    187       {ECO:0000244|PDB:2C81}.
FT   STRAND      192    194       {ECO:0000244|PDB:2C81}.
FT   STRAND      196    198       {ECO:0000244|PDB:2C81}.
FT   STRAND      200    205       {ECO:0000244|PDB:2C81}.
FT   HELIX       207    217       {ECO:0000244|PDB:2C81}.
FT   STRAND      221    223       {ECO:0000244|PDB:2C81}.
FT   HELIX       227    229       {ECO:0000244|PDB:2C81}.
FT   STRAND      235    239       {ECO:0000244|PDB:2C81}.
FT   HELIX       252    262       {ECO:0000244|PDB:2C81}.
FT   HELIX       265    283       {ECO:0000244|PDB:2C81}.
FT   STRAND      289    291       {ECO:0000244|PDB:2C81}.
FT   STRAND      298    300       {ECO:0000244|PDB:2C81}.
FT   STRAND      304    310       {ECO:0000244|PDB:2C81}.
FT   HELIX       312    314       {ECO:0000244|PDB:2C81}.
FT   TURN        315    317       {ECO:0000244|PDB:2C81}.
FT   HELIX       320    331       {ECO:0000244|PDB:2C81}.
FT   TURN        335    337       {ECO:0000244|PDB:2C81}.
FT   HELIX       345    347       {ECO:0000244|PDB:2C81}.
FT   HELIX       353    355       {ECO:0000244|PDB:2C81}.
FT   HELIX       361    364       {ECO:0000244|PDB:2C81}.
FT   HELIX       367    371       {ECO:0000244|PDB:2C81}.
FT   HELIX       376    384       {ECO:0000244|PDB:2C81}.
FT   STRAND      385    389       {ECO:0000244|PDB:2C81}.
FT   HELIX       390    394       {ECO:0000244|PDB:2C81}.
FT   HELIX       397    412       {ECO:0000244|PDB:2C81}.
SQ   SEQUENCE   418 AA;  47032 MW;  41E7C1102D36D289 CRC64;
     MTIPFDHWPE WPQHSDRTRR KIEEVFQSNR WAISGYWTGE ESMERKFAKA FADFNGVPYC
     VPTTSGSTAL MLALEALGIG EGDEVIVPSL TWIATATAVL NVNALPVFVD VEADTYCIDP
     QLIKSAITDK TKAIIPVHLF GSMANMDEIN EIAQEHNLFV IEDCAQSHGS VWNNQRAGTI
     GDIGAFSCQQ GKVLTAGEGG IIVTKNPRLF ELIQQLRADS RVYCDDSSEL MHGDMQLVKK
     GDIQGSNYCL SEFQSAILLD QLQELDDKNA IREKNAMFLN DALSKIDGIK VMKRPPQVSR
     QTYYGYVFRF DPVKFGGLNA DQFCEILREK LNMGTFYLHP PYLPVHKNPL FCPWTKNRYL
     KSVRKTEAYW RGLHYPVSER ASGQSIVIHH AILLAEPSHL SLLVDAVAEL ARKFCVTH
//
